Amoxycillin levels in sputum, serum, and saliva
Reads0
Chats0
TLDR
It was not possible to demonstrate any relationship between the purulence of the sputum and the level of ampicillin after doses of 250 mg.Abstract:
The ampicillin levels in sputum, serum, and saliva from 40 patients receiving a dose of 250 mg., 26 patients receiving a dose of 500 mg., and 11 patients receiving a dose of 1 g. were estimated. The ampicillin was given orally four times daily. The 1-2 hour and 2-3 hour sputum levels were similar in individual patients. There was no difference in the range or mean sputum or saliva levels between specimens from patients receiving 250 mg. and 500 mg., but the levels were significantly higher after the 1 g. dose. The mean serum level showed a small increase after 500 mg. ampicillin as compared with the 250 mg. dose and a big increase after the 1 g. dose: only the latter difference was significant. The sputum levels were approximately 30 to 40 times lower than the corresponding serum levels. There was considerable scatter in the sputum level for any level of ampicillin in the serum: in only two of the 1-2 hour sputum specimens was there no detectable ampicillin. There was no correlation between the sputum levels and either the body weight or the dose in milligrams per kilogram. There was no evidence that corticosteroids or diuretics affected the sputum level. It was not possible to demonstrate any relationship between the purulence of the sputum and the level of ampicillin after doses of 250 mg. or 500 mg., but higher levels were found in the more purulent specimens after 1 g. doses.read more
Citations
More filters
Journal ArticleDOI
Penetration of Antibiotics into Respiratory Secretions
TL;DR: The various influences on antibiotic concentrations in the lung are discussed, a canine model for detailed pharmacologic studies of antibiotics in bronchial secretion is described, and optimal methods of antibiotic therapy for lung infection may depend on the specific minimal inhibitory concentration for the infecting organism.
Journal ArticleDOI
Pulmonary disposition of antimicrobial agents: methodological considerations.
TL;DR: In this paper, the authors propose a method to solve the problem of image compression: https://www.spline.com/images/image-clips/imageclips.html
Journal ArticleDOI
Tobramycin: A Review of its Antibacterial and Pharmacokinetic Properties and Therapeutic Use
TL;DR: Tobramycin is a new aminoglycoside antibiotic with a broad antibacterial spectrum in vitro, and pharmacokinetic properties similar to those for gentamicin, and appears to offer no clear advantages over gentamicIn against sensitive organisms it is indicated in infection caused by strains of P. aeruginosa.
Journal ArticleDOI
Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.
TL;DR: The rationale for measuring the concentrations of antimicrobial agents at potential sites of infection other than serum is that pathogens may be confined to sites which are separated from the blood by significant barriers to antimicrobial agent movement.
Journal ArticleDOI
The Clinical Relevance of Protein Binding and Tissue Concentrations in Antimicrobial Therapy
TL;DR: The degree of tissue penetration (protein binding apart) is related to clinical efficacy in urinary tract infections, chest infections and meningitis where experimental data are firm but clinical information less readily available.
References
More filters
Journal ArticleDOI
Absorption and excretion of "Penbritin".
TL;DR: Since penbritin is highly stable in acid medium it could be well absorbed orally, experiments were designed to investigate the serum concentrations and urinary excretions obtained with various oral doses of the new penicillin.
Journal ArticleDOI
The mucosal epithelium of the respiratory tract in muco-purulent bronchitis caused by Haemophilus influenzae.
J. F. P. Hers,J. Mulder +1 more
Journal ArticleDOI
"Indirect pathogenicity" of penicillinase-producing enterobacteria in chronic bronchial infections.
J.L. Maddocks,J.Robert May +1 more
TL;DR: Although enterobacteria are usually non-pathogenic in chronic bronchial disorders they may produce enough penicillinase to destroy ampicillin administered for an underlying infection caused by Hœmophilus influenzœ, interference withAmpicillin therapy was demonstrated.
Journal Article
-amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man.
Croydon Ea,Sutherland R +1 more
Related Papers (5)
TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN Some Pharmacological Observations
J. Robert May,DoreenM. Delves +1 more